AIM WINNERS & LOSERS: Eagle Eye wins new deal; CNS interim loss widens
(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday. Read More
| Price | 284.00p on 02-12-2025 at 19:40:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 290.00p |
| Sell | 278.00p |
| Last Trade: | Buy 692.00 at 287.00p |
| Day's Volume: | 219,120 |
| Last Close: | 284.00p |
| Open: | 284.00p |
| ISIN: | GB00BKF1YD83 |
| Day's Range | 284.00p - 284.00p |
| 52wk Range: | 194.00p - 488.00p |
| Market Capitalisation: | £84.88m |
| VWAP: | 280.67225p |
| Shares in Issue: | 29.89m |
Sector: Software and Computing
Listed In: FTSE AIM All-Share,
Eagle Eye (EYE) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 692 | 287.00p | Ordinary |
16:07:08 - 02-Dec-25 |
| Unknown* | 18,391 | 281.00p | Ordinary |
12:26:03 - 02-Dec-25 |
| Buy* | 1,737 | 287.50p | Ordinary |
10:36:03 - 02-Dec-25 |
| Buy* | 1,000 | 286.50p | Ordinary |
10:01:58 - 02-Dec-25 |
| Buy* | 1,500 | 285.00p | Ordinary |
10:00:33 - 02-Dec-25 |
| Unknown* | 500 | 284.00p | Ordinary |
09:57:11 - 02-Dec-25 |
| Unknown* | 50,000 | 280.50p | Negotiated Trade |
09:48:36 - 02-Dec-25 |
| Unknown* | 50,000 | 280.00p | Negotiated Trade |
09:48:26 - 02-Dec-25 |
| Sell* | 5,000 | 280.00p | Ordinary |
09:20:33 - 02-Dec-25 |
| Unknown* | 25,000 | 280.00p | Negotiated Trade |
09:19:22 - 02-Dec-25 |
Eagle Eye (EYE) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 2nd Dec 2025 1:56 pm | RNS | Issue of Equity |
| 1st Dec 2025 7:00 am | RNS | Transaction in Own Shares |
| 28th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 27th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 26th Nov 2025 12:15 pm | RNS | Issue of Equity |
| 25th Nov 2025 4:15 pm | RNS | Notification of major holdings |
| 24th Nov 2025 5:35 pm | RNS | Notification of major holdings |
| 24th Nov 2025 7:00 am | RNS | Issue of Equity |
| 24th Nov 2025 7:00 am | RNS | Transaction in Own Shares |
| 21st Nov 2025 7:00 am | RNS | PDMR shareholding and issue of equity |